Abstract Total synthesis of a fungal cyclic peptide, malformin C, recently rediscovered as a G2 checkpoint inhibitor was completed. Our synthesis involved a convergent approach with respect to a linear pentapeptide, cyclization, and oxidative disulfide formation.
Introduction
Spontaneous and chemical damage to DNA induces signal transduction pathways called checkpoints, which delay cell cycle progression and repair of DNA [1] . DNA damage in normal human cells can be repaired in both the G1 and G2 phases. In contrast, most cancer cells can restore DNA damage only in the G2 phase due to mutations in genes for the G1 checkpoint. Therefore, an inhibitor of the G2 checkpoint in cancer cells is expected to be a selective potentiator of DNA-damaging agents and thus useful for the treatment of cancer.
Recently, malformins A1 and C ( Fig. 1) , isolated from the culture broth of Aspergillus niger FKI-2342, were found to abrogate the bleomycin-induced G2 arrest in Jurkat cells with IC 50 values of 480 nM and 0.9 nM, respectively [2] . Malformin A1 is a bicyclic pentapeptide containing one L-isoleucine, one D-leucine, one L-valine, and two D-cysteines, while malformin C has L-leucine instead of L-isoleucine. Interestingly, this slight structural difference of the side-chains has an influence on the inhibitory activity. Consequently, malformin C is a promising candidate as a potentiator of anti-cancer agents. Although malformins are also known to show a variety of activities such as inducing root curvatures and malformations in plants, antibacterial activity and enhanced fibrinolytic activity [3ϳ6], the interesting bioactivity of malformin C, as well as its bicyclic structure with a disulfide-bond bridge, prompted us to study the synthesis of this class of cyclic peptides. Herein, we describe a synthesis of malformin C.
Results and Discussion
We planned to undertake the synthesis of malformin C via a convergent approach, involving preparation and coupling of tripeptide (1) and dipeptide (2) to allow creation of linear Total Synthesis of Malformin C, an Inhibitor of BleomycinInduced G2 Arrest pentapeptide (3), which should undergo cyclization and oxidative disulfide formation (Scheme 1). The less hindered amide bond between D-cysteine and L-valine was chosen for cyclization because the cyclization position between Dleucine and L-isoleucine has already been investigated in the stepwise synthesis of malformin A1 [7] .
Total synthesis of malformin C is shown in Scheme 2. Coupling of L-leucine benzyl ester (4) and Boc-D-leucine, followed by removal of the Boc group with 4.0 N HCl/dioxane provided dipeptide (5), which was subjected to condensation of Fmoc-L-valine. Hydrogenolysis of the benzyl group proceeded in a catalytic amount of Pd(OH) 2 at 40°C to give tripeptide 1. Heating was necessary to dissolve the Fmoc protected tripeptide in ethyl acetate. D-S-Tritylcystein allyl ester (7) was prepared from commercially available Fmoc-D-S-tritylcystein (6) by allylation of the carboxylic acid, followed by deprotection of the Fmoc group. After coupling of 6 and 7, dipeptide 2 was obtained by deprotection of the Fmoc group with piperidine. Coupling of 1 and 2 using HBTU/HOBt provided linear peptide (8) in 93% yield. Cyclization precursor 3 was obtained by removal of the Fmoc group, followed by hydrolysis of the Allyl group with aq NaOH. In the deprotection of the Allyl group, palladium-catalyzed reaction with dimedone resulted in poor yield. With linear peptide 3 in hand, we examined the effect of conditions on cyclization. After several attempts, combination of HATU and HOAt under high dilution conditions (1.0 mM) at 0°C afforded the cyclic peptide in 69% yield. Other coupling reagents such as HBTU/HOBt and PyBop reduced the yields (44 and 34%). Finally, oxidative disulfide formation with iodine in DMF smoothly proceeded, resulting in malformin C in 85% yield after silica gel chromatography. Its yield was reduced to 26% when 10% MeOH/CH 2 Cl 2 was used as a solvent system. Spectra data of the synthetic malformin C were found to be identical to those of the natural product.
In conclusion, we have demonstrated a synthesis of malformin C, a fungal cyclic peptide, in 9 steps and 30% overall yield. The results could be exploited to generate malformin derivatives for elucidation of the structureactivity relationships. Further studies on in vivo activities and solid phase synthesis of malformin derivatives are in progress.
Experimental
Reagents were purchased at highest commercial quality and used without further purification, unless otherwise specified. Reactions were monitored by TLC using Merck F60 254 silica gel plates. Spots were visualized with UV light (254 nm) and stained with phosphomolybdic acid and ninhydrin. Silica gel chromatography was performed on a Merck Kieselgel 60 (Art. 1.09385).
FT-IR spectra were recorded in KBr pellets on a Horiba FT-210 spectrometer. Mass spectra were recorded on a JEOL JMS-700V Mass Spectrometer.
1 H-NMR spectra were recorded on a JEOL JNM-EX270 spectrometer in CDCl 3 or pyridine-d 5 .
1 H-NMR spectral data are reported as follows: chemical shifts relative to CHCl 3 (7.26 ppm) or pyridine (8.71 ppm), integration, multiplicity (sϭsinglet, dϭdoublet, tϭtriplet, qϭquartet, mϭmultiplet, brϭbroad) and coupling constant. Optical rotation was obtained with a JASCO DIP-370 polarimeter. 13 C-NMR spectral data are reported in ppm relative to CHCl 3 (77.0 ppm) or pyridine (135.5 ppm). Melting points were measured with a Yanaco micromelting point apparatus.
Benzyl (N-tert-Butoxycarbonyl-D-leucinyl)-L-leucinate
To a solution of 4 (3.27 g, 9.63 mmol) in CH 2 Cl 2 (80 ml) were added N-Boc-D-Leu (2.0 g, 8.02 mmol), DIPEA (3.07 ml, 17.6 mol), HOBt (2.60 g, 19.3 mmol) and EDCl (1.85 g, 9.63 mmol) at 0°C, and the mixture was stirred at room temperature for 2 hours. The reaction was quenched with H 2 O, and the resulting mixture was extracted with CHCl 3 . The organic extracts were washed with saturated aq NH 4 Cl, saturated aq NaHCO 3 and brine, dried over Na 2 SO 4 , filtered, and concentrated. The residue was purified by flash column chromatography on silica gel (hexane/EtOAcϭ5/1 to 4/1) to give the dipeptide (3.40 
Benzyl D-Leucinyl-L-leucinate Hydrochloride (5)
To a solution of dipeptide (3.40 g, 7.82 mmol) was added 4.0 N HCl/dioxane (39 ml) at 0°C, and the mixture was stirred at same temperature for 2 hours. The reaction mixture was concentrated to give 5 as a white solid. The title compound was used for subsequent reaction without further purification. 
Allyl N-9-Fluorenylmethyloxycarbonyl-D-Stritylcysteinate
To a solution of 6 (586 mg, 1.00 mmol) in H 2 O/MeOH (1/1, 10 ml) was added Cs 2 CO 3 (196 mg, 0.6 mmol) at 0°C. After stirring at room temperature for 1 hour, the reaction mixture was concentrated. The residue was dissolved in DMF (2.0 ml), and then allyl bromide (173 ml, 2.0 mmol) was added at 0°C. The mixture was stirred at room temperature for 9.5 hours. 131.2, 129.5, 129.3, 128.0, 127.9, 127.7, 127.0, 126.8 
Allyl D-S-Tritylcysteinyl-D-S-tritylcysteinate (2)
A mixture of the dipeptide (67.5 mg, 69.5 m mol) in piperidine/CH 2 Cl 2 (1/4, 0.70 ml) was stirred at 0°C for 1.5 hours. The reaction was quenched with H 2 O, and the resulting mixture was extracted with CHCl 3 . The organic extracts were washed with saturated aq NH 4 Cl and brine, dried over Na 2 SO 4 , filtered, and concentrated. The residue was purified by flash column chromatography on silica gel (hexane/EtOAcϭ5/1 to 1/1) to give 2 (42. 144.1, 143.7, 143.6, 141.1, 131.1, 129.5, 129.4, 129.3 
L-Valinyl-D-leucinyl-L-leucinyl-D-S-tritylcysteinyl-D-Stritylcysteine (3)
To a solution of the amine (38.7 mg, 360 m mol) in THF/H 2 O (4/1, 0.72 ml) was added NaOH (2.16 mg, 540 mmol) at 0°C, and the mixture was stirred at 0°C for 1 hour. The reaction temperature was warmed to room temperature. After stirring at the same temperature for 5 hours, the reaction was quenched with 0.1 N HCl (540 ml), and the resulting mixture was extracted with CHCl 3 . The organic extracts were concentrated, and the residue was purified by flash column chromatography on silica gel (CHCl 3 
